Clinical Trial

Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Assess serum and tissue retinol binding protein 4 in patients with severe alopecia areata in correlation with healthy individuals . Estimate genetic profile of retinol binding protein4 in severe alopecia areata patients Assess possible role of retinol binding protein 4 genetic mutation in response to barcitinib treatment in patients with severe alopecia areata .
Trial Details
NCT Number NCT06545110
Lead Sponsor South Valley University
Conditions Alopecia Areata
Enrollment 120 participants
Start Date 2023-09-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-09